Shilajit
Herbo-mineral resin
Also known as mumie, moomiyo, purified shilajit, PrimaVie, fulvic acid resin, mumijo
A tar-like resin from Himalayan rock, used in Ayurveda for centuries. One small 90-day trial raised testosterone in men aged 45 to 55; one 8-week trial reduced strength loss after fatigue. Both used the same purified extract. Raw resin has tested over heavy-metal limits.
What doses have been studied? What each trial gave, with the population it was given to.
Overview
In shortShilajit is a tar-like resin that seeps from Himalayan rock, used in Ayurveda for centuries and sold to men for testosterone and energy. The human trials are few and recent, and nearly all test one purified extract from one maker. That cuts both ways: the results may not apply to raw resin, and raw resin carries a heavy-metal problem the purified extract exists to remove.
Shilajit is a blackish-brown exudate that seeps from rock in the Himalaya and other mountain ranges, formed over long periods from decomposed plant matter. It is made of humic substances, mainly fulvic acids, together with dibenzo-alpha-pyrones and a long list of minerals. In Ayurvedic medicine it is a rasayana, a rejuvenator, and in Russian and Central Asian folk medicine the same material is mumie or moomiyo.
It is sold to men for testosterone, strength and energy, which is why it sits in this section. The human trial literature is small and recent, and nearly all of it tests a purified, standardized extract, several trials the same branded one. That matters twice over: the results may not transfer to the raw resin sold in jars, and the raw resin carries a heavy-metal problem the purified extract was designed to remove.
Mechanism
In shortIts fulvic acids and related molecules are proposed to help cells make energy and act as antioxidants, with animal and lab work behind that. In people, 14 weeks of the extract switched on genes for blood vessel growth in skin and muscle. These are leads rather than a proven mechanism.
The constituents the literature credits are fulvic acid and dibenzo-alpha-pyrones, which are proposed to support mitochondrial ATP production, carry electrons in the respiratory chain, and act as antioxidants. A 2014 review collects animal and in vitro work for antioxidant, anti-inflammatory, adaptogenic and immunomodulatory effects, and for enhanced spermatogenesis in animals. In humans, a 2019 placebo-controlled transcriptome study found 14 weeks of the extract turned on genes involved in blood vessel growth and extracellular matrix in skin and improved skin microperfusion, and the same group had earlier reported extracellular matrix genes induced in muscle. These are leads, not an established mechanism, and the dose that produces them in people is not known.
Evidence
In shortIn men aged 45 to 55, 90 days of the purified extract raised testosterone against placebo, though the abstract gives no numbers. In 63 young men, 8 weeks at 500 mg a day cut strength loss after fatigue, but only in the stronger half. In 60 postmenopausal women, 48 weeks slowed bone loss. Every trial is small and manufacturer-supplied; none has been independently repeated.
Testosterone. The trial that sells the product: healthy men aged 45 to 55 took 250 mg of purified shilajit twice a day or placebo for 90 days in a randomized, double-blind trial. Total testosterone, free testosterone and DHEAS rose significantly compared with placebo, with LH and FSH unchanged. The abstract gives no numbers and no sample size. A 2024 systematic review of 52 trials of 27 proposed testosterone boosters found most fail to raise total testosterone, and listed purified shilajit among the few it rated possibly effective, and only for men with late-onset hypogonadism.
Strength and fatigue. In the strength trial, 63 recreationally active young men took 250 mg per day, 500 mg per day or placebo for 8 weeks. In the stronger half of the sample, the 500 mg group lost less maximal strength after a fatiguing protocol (8.9% decline against 16% on placebo and 17% on the low dose) and had lower serum hydroxyproline, a marker of collagen breakdown. The low dose did nothing measurable, and the headline result comes from a subgroup.
Bone. In a 48-week trial, 60 postmenopausal women with osteopenia took 250 mg, 500 mg or placebo daily. Bone density at spine and hip fell on placebo and the fall was attenuated, dose-dependently, on the extract, with bone turnover, oxidative stress and CRP markers moving the same way. Not a men's health trial, but the longest and best-run one in the file.
Open-label. A 2026 pilot gave 25 healthy men 500 mg per day of a resin product for 28 days with no control group and reported strength, endurance and fatigue improvements. Without a placebo arm those numbers are not evidence of anything.
The whole clinical file is a handful of trials, each of 25 to 63 people, each funded or supplied by a manufacturer, and none replicated independently.
Safety
In shortThe trials reported no side effects over up to 48 weeks. The risk is the product, not the extract: raw shilajit is a rock exudate, and a 2022 analysis of widely sold Indian and Pakistani shilajit found lead, arsenic and mercury above permissible limits. Buy tested, purified product or not at all, and tell a clinician if you have prostate disease or take hormones.
In the trials, no adverse effects were reported over periods up to 48 weeks, and the 2014 review calls safety well documented in animal and human studies. The problem is not the trial product but the market.
Shilajit is a mineral exudate and carries whatever metals the rock carried. A 2022 analysis of the Indian and Pakistani shilajit most widely sold found aluminum, strontium, manganese, barium, zinc, nickel, boron, chromium, lead, arsenic and mercury in amounts exceeding permissible limits. A 2024 review counted around 65 metals reported in shilajit, including lead, arsenic, cadmium and mercury, and concluded that consumption without knowing the metal content is not safe. Purified, standardized extracts exist precisely because of this; a raw resin bought online may or may not have been tested, and the label will not tell you.
It is also sold as a testosterone product, so the usual cautions apply: anyone with prostate disease, or on hormone treatment, should not add it without a clinician knowing.
Regulatory status
In shortA traditional Ayurvedic medicine in India and a supplement everywhere else, with no claims reviewed and no approvals for anything. Herbal products have heavy-metal limits in most countries, and published testing suggests some shilajit on sale breaks them.
A traditional Ayurvedic preparation in India and a dietary supplement in the United States, the United Kingdom and the European Union, sold without review of its claims. No regulator has approved it for testosterone, strength or anything else. Heavy-metal limits for herbal products exist in most jurisdictions, and the published analyses suggest some products on sale exceed them.
The literature
9 studies indexed. Findings and limitations get equal weight, on purpose.
Members area
The Shilajit literature needs an account
Everything above is free to read. What an account opens is the evidence underneath it: 9 studies with their limitations, and the regimen each trial actually reported.
- Every study, with what it found and what it cannot show
- The limitations, given the same weight as the findings
- The dose each named trial administered, where recorded
Free to create. A membership is separate, and you can decide about that later.
Reading is free, an account is not the same as paying. 80 compound guides, every study with its limitations written underneath, and the regimens those trials actually used. A free account opens all of it. A membership is a separate decision, and it opens the forum. What membership costs.
The wider literature
14 indexed papers and 3 registered trials mentioning Shilajit, straight from PubMed and ClinicalTrials.gov. 2 of 3 administer it; the rest measure it. These have not been read by us. Unlike the studies above, they carry no findings and no limitations written by anyone here, because writing either would mean claiming a reading nobody has done. They are a starting point for yours.
Registered trials (3)
- Impact of Chromium, Phyllanthus Emblica, and Shilajit on Cardiovascular Health, Fitness, and Weight Loss During Exercise and Diet Programs
Kerry Group P.L.C2019NCT06641596
interventionalnacompletedn=112
- Natreon Healthy Skin Study - PrimaVie Supplement
Ohio State University2016NCT02762032
interventionalphase1completedn=45
- Effects of PrimaVie and Exercise Training on Human Skeletal Muscle (PrimaVie)
Sanni Raju2014NCT02026414
interventionalnacompletedn=29
Papers (14)
- Shilajit extract (ZhaXun) protects against acetaminophen-induced liver injury via modulation of the NF-κB/AKT/Caspase-3 axis.
He SQ, et al.Journal of ethnopharmacology2026PMID 40957543
journal article
- A Comprehensive Review on Shilajit: What We Know about Its Chemical Composition.
Kamgar E, et al.Critical reviews in analytical chemistry2025PMID 38133965
journal articlereview
- Do "testosterone boosters" really increase serum total testosterone? A systematic review.
Morgado A, et al.International journal of impotence research2024PMID 37697053
journal articlesystematic review
- Mumio (Shilajit) as a potential chemotherapeutic for the urinary bladder cancer treatment.
Kloskowski T, et al.Scientific reports2021PMID 34799663
journal article
- Nanoscale Calcium Salt-Based Formulations As Potential Therapeutics for Osteoporosis.
Dashnyam K, et al.ACS biomaterials science & engineering2020PMID 33455197
journal articleresearch support, non-u.s. gov't
- Profertility effects of Shilajit on cadmium-induced infertility in male mice.
Mishra RK, et al.Andrologia2018PMID 29947420
journal article
- Clinical evaluation of purified Shilajit on testosterone levels in healthy volunteers.
Pandit S, et al.Andrologia2016PMID 26395129
journal articlerandomized controlled trial
- Mumic acids A-E: new diterpenoids from mumiyo.
Kiren Y, et al.Journal of natural medicines2014PMID 23609027
journal articleresearch support, non-u.s. gov't
- Evaluation of safety profile of black shilajit after 91 days repeated administration in rats.
Velmurugan C, et al.Asian Pacific journal of tropical biomedicine2012PMID 23569899
journal articleresearch support, non-u.s. gov't
- Shilajit: a review.
Agarwal SP, et al.Phytotherapy research : PTR2007PMID 17295385
journal articleresearch support, non-u.s. gov'treview
- Shilajit: evalution of its effects on blood chemistry of normal human subjects.
Sharma P, et al.Ancient science of life2003PMID 22557121
journal article
- Effects of Shilajit on the development of tolerance to morphine in mice.
Tiwari P, et al.Phytotherapy research : PTR2001PMID 11268125
journal article
- Pharmacological actions of Shilajit.
Acharya SB, et al.Indian journal of experimental biology1988PMID 3248832
journal articleresearch support, non-u.s. gov't
- Shilajit I: chemical constituents.
Ghosal S, et al.Journal of pharmaceutical sciences1976PMID 932958
journal article
Discussion
Shilajit has its own forum, and sits in Testosterone & Hormones. Every post says what kind of claim it makes.
Nobody has posted about Shilajit yet.
Membership
Supplements are free. The argument is for members.
The guide above is open to everyone, and the literature underneath it opens with a free account. That is the educational half of this site. Reading and joining the discussion around Shilajit, and every other entry, is what membership pays for.
For Research & Educational Discussion Only. Not Medical Advice
This guide is educational reference material compiled from published literature. It is not medical advice, not a recommendation, and not a substitute for a clinician who knows your history. Nothing here should be used to make a decision about your own health without one.
Talk to a licensed healthcare professional.